This protocol is specific to pyogenic granuloma arising in the ocular, orbital, or periocular region — including lesions on the palpebral or bulbar conjunctiva. This anatomical location calls for a treatment strategy tailored to the ophthalmic setting.
The management approach involves a topical ophthalmic therapy applied directly to the granuloma. The treatment goal is complete resolution of the lesion, assessed over a structured follow-up period.
The complete regimen — including the specific agent, application details, and monitoring schedule — is contained in the full protocol.
DOI: 10.1097/GOX.0000000000006160
A recent prospective study highlighted the efficacy of topical 0.5% timolol eye drops, particularly in ophthalmic PG cases, with 77.5% achieving an excellent response, complete resolution over a 6-month follow-up, and no complications.
View source ↗